NIH-funded study lays groundwork for potential application submission to FDA for licensure of islet preparation
Bethesda, Maryland–(ENEWSPF)–April 18, 2016. New clinical trial results show that transplantation of pancreatic islets — cell clusters that contain insulin-producing cells—prevents severe, potentially life-threatening drops in blood sugar in people with type 1 diabetes. Researchers found that the treatment was effective for people who experienced episodes of severe hypoglycemia — low blood sugar levels that can lead to seizures, loss…
